Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Cyclophilin A Function in Mammary Epithelium Impacts Jak2/Stat5 Signaling, Morphogenesis, Differentiation, and Tumorigenesis in the Mammary Gland.

Volker SE, Hedrick SE, Feeney YB, Clevenger CV.

Cancer Res. 2018 Jul 15;78(14):3877-3887. doi: 10.1158/0008-5472.CAN-17-2892. Epub 2018 Jun 29.

PMID:
29959151
2.

HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth.

Medler TR, Craig JM, Fiorillo AA, Feeney YB, Harrell JC, Clevenger CV.

Mol Cancer Res. 2016 Oct;14(10):994-1008. Epub 2016 Jun 29.

3.

Immunoassay and Nb2 lymphoma bioassay prolactin levels and mammographic density in premenopausal and postmenopausal women the Nurses' Health Studies.

Rice MS, Tworoger SS, Bertrand KA, Hankinson SE, Rosner BA, Feeney YB, Clevenger CV, Tamimi RM.

Breast Cancer Res Treat. 2015 Jan;149(1):245-53. doi: 10.1007/s10549-014-3232-z. Epub 2014 Dec 13.

4.

Bioactive prolactin levels and risk of breast cancer: a nested case-control study.

Tworoger SS, Rice MS, Rosner BA, Feeney YB, Clevenger CV, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):73-80. doi: 10.1158/1055-9965.EPI-14-0896. Epub 2014 Oct 14.

5.

Hormonal determinants of nipple aspirate fluid yield among breast cancer cases and screening controls.

Fought AJ, McGathey C, Scholtens DM, Heinz RE, Lowe R, Feeney YB, Lee O, Kmiecik TE, Wolfman JA, Clevenger CV, Gann PH, Gapstur S, Chatterton RT, Khan SA.

Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2277-84. doi: 10.1158/1055-9965.EPI-12-0434. Epub 2013 Sep 18.

6.

The prolactin receptor transactivation domain is associated with steroid hormone receptor expression and malignant progression of breast cancer.

Fiorillo AA, Medler TR, Feeney YB, Wetz SM, Tommerdahl KL, Clevenger CV.

Am J Pathol. 2013 Jan;182(1):217-33. doi: 10.1016/j.ajpath.2012.09.021. Epub 2012 Nov 14.

7.

HMGN2 inducibly binds a novel transactivation domain in nuclear PRLr to coordinate Stat5a-mediated transcription.

Fiorillo AA, Medler TR, Feeney YB, Liu Y, Tommerdahl KL, Clevenger CV.

Mol Endocrinol. 2011 Sep;25(9):1550-64. doi: 10.1210/me.2011-0106. Epub 2011 Aug 4.

8.

Prolactin receptor-integrin cross-talk mediated by SIRPĪ± in breast cancer cells.

Galbaugh T, Feeney YB, Clevenger CV.

Mol Cancer Res. 2010 Oct;8(10):1413-24. doi: 10.1158/1541-7786.MCR-10-0130. Epub 2010 Sep 8.

9.

Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer.

Zheng J, Koblinski JE, Dutson LV, Feeney YB, Clevenger CV.

Cancer Res. 2008 Oct 1;68(19):7769-78. doi: 10.1158/0008-5472.CAN-08-0639.

Supplemental Content

Loading ...
Support Center